Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,286 | Dovepress* | 8,621+ | 871 | 9,492 | |
PubMed Central* | 665 | 234 | 899 | ||
Totals | 9,286 | 1,105 | 10,391 | ||
*Since 30 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar